Cargando…

A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients

BACKGROUND: Classical MPNs including ET and PMF have a chronic course and potential for leukaemic transformation. Timely diagnosis is obligatory to ensure appropriate management and positive outcomes. The aim of this study was to determine the mutational profile, clinical characteristics and outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaidi, Uzma, Sufaida, Gul, Rashid, Munazza, Kaleem, Bushra, Maqsood, Sidra, Mukry, Samina Naz, Khan, Rifat Zubair Ahmed, Munzir, Saima, Borhany, Munira, Shamsi, Tahir Sultan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069043/ https://www.ncbi.nlm.nih.gov/pubmed/32164591 http://dx.doi.org/10.1186/s12885-020-6700-3

Ejemplares similares

Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients
por: Zaidi, Uzma, et al.
Publicado: (2019)

Thrombocytopenia in Pregnancy: Identification and Management at a Reference Center in Pakistan
por: Borhany, Munira, et al.
Publicado: (2022)

Laboratory Diagnosis of Malaria: Comparison of Manual and Automated Diagnostic Tests
por: Mukry, Samina Naz, et al.
Publicado: (2017)

Influence of cytochrome P450 and glutathione S transferase polymorphisms on response to nilotinib therapy among chronic myeloidleukemia patients from Pakistan
por: Mukry, Samina Naz, et al.
Publicado: (2022)

Genomic profile of a patient with triple negative essential thrombocythemia, unresponsive to therapy: A case report and literature review
por: Zaidi, Uzma, et al.
Publicado: (2017)

CLINICAL RELEVANCE OF EXTENDED PLATELET INDICES IN THE DIAGNOSIS OF IMMUNE THROMBOCYTOPENIA
por: Arshad, Aisha, et al.
Publicado: (2021)

Evaluation of efficacy of serological methods for detection of HCV infection in blood donors: A single centre experience
por: Naz, Arshi, et al.
Publicado: (2018)

Possible correlation of electrochemiluminescence based numerical cut off index value with concentration of anti-SARS-CoV-2 antibody: Is it worth reporting?
por: Khawaja, Shabnum, et al.
Publicado: (2021)

Peripheral Blood Stem Cell Harvest HPC Count Is an Effective Surrogate Marker for CD34+ Cell Count in Allogeneic Stem Cell Transplant Setting
por: Jamal, Aisha, et al.
Publicado: (2020)

Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura
por: Naz, Arshi, et al.
Publicado: (2016)

Recent advances in understanding myelofibrosis and essential thrombocythemia
por: Vainchenker, William, et al.
Publicado: (2016)

Homozygous CALR Mutation in Primary Myelofibrosis and Its Effect on Disease Phenotype: A Case Report and Review of the Literature
por: Rizvi, Qurratulain, et al.
Publicado: (2019)

The Impact of ABO Incompatibility on the Outcomes of Hematopoietic Stem Cell Transplantation: A Single-Center Study From Pakistan
por: Borhany, Munira, et al.
Publicado: (2023)

Chromosomal Breakage in Fanconi Anemia and Consanguineous Marriages: A Social Dilemma for Developing Countries
por: Siddiqui, Fakeha, et al.
Publicado: (2020)

Expression of aberrant antigens in hematological malignancies: A single center experience
por: Shahni, Aneeta, et al.
Publicado: (2018)

Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan
por: Khan, Tehmina Nafees Sonia, et al.
Publicado: (2021)

The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia
por: Conchon, Monika
Publicado: (2011)

The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Population pharmacokinetics of fedratinib in patients with myelofibrosis, polycythemia vera, and essential thrombocythemia
por: Ogasawara, Ken, et al.
Publicado: (2019)

Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
por: Tefferi, A, et al.
Publicado: (2017)

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
por: Carobbio, Alessandra, et al.
Publicado: (2023)

Blood Ordering and Transfusion Practices: An Insight Toward Better Utility of Blood Products
por: Waheed, Samra, et al.
Publicado: (2022)

Prevalence of transfusion transmissible infections in blood donors of Pakistan
por: Arshad, Aisha, et al.
Publicado: (2016)

Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan
por: Younas, Amber, et al.
Publicado: (2020)

Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia
por: dos Santos, Leonardo Caires, et al.
Publicado: (2011)

P1047: REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN CHINA
por: Xu, Z., et al.
Publicado: (2022)

Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
por: Schalling, Martin, et al.
Publicado: (2017)

Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
por: Mora, Barbara, et al.
Publicado: (2019)

Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
por: Murata, Makoto, et al.
Publicado: (2020)

Coexistence of Post-essential Thrombocythemia Myelofibrosis With Monoclonal Gammopathy of Undetermined Significance: A Case Report
por: Allam, Sarvani Reddy, et al.
Publicado: (2022)

Easily Applicable Predictive Score for Differential Diagnosis of Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia
por: Lekovic, Danijela, et al.
Publicado: (2023)

Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial
por: Pardanani, A, et al.
Publicado: (2015)

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
por: Barbui, T, et al.
Publicado: (2015)

Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria
por: Rumi, Elisa, et al.
Publicado: (2017)

Bleeding disorders in the tribe: result of consanguineous in breeding
por: Borhany, Munira, et al.
Publicado: (2010)

Complex Karyotype in Hematological Diseases: A 6-Year Single Centre Study from Pakistan
por: Waheed, Samra, et al.
Publicado: (2018)

JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis
por: Kim, Bo Hyun, et al.
Publicado: (2015)

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
por: Agarwal, M. B., et al.
Publicado: (2015)

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
por: Yönal, İpek, et al.
Publicado: (2016)

Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia
por: Pimpinelli, Fulvia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fm1rn3djuvu845is0pabphnp8q